Efficacy And Safety Data From A Phase 1/2 Trial Of Tislelizumab In Chinese Patients With Non-Small Cell Lung Cancer (Nsclc) Q. Zhou, J. Zhao, J. Wang,Q. Zhang, H. Pan, L. Shen, Y. Yuan, Y. Bai,T. Liu,Y. Gao,Y. Li,J. Zhang,Y. -L. WuJOURNAL OF THORACIC ONCOLOGY（2021）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
